Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Melatonin With Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
NCT07503600Phase 3Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of melatonin in Gram-negative bacterial infection, sponsored by Ain Shams University. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on NCT07503600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07503600.